🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 16 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/11/2004 22,30 23,20 22,30 23,10 +3,59% 4,04% 2.390
23/11/2004 22,70 22,70 22,30 22,30 -0,45% 1,76% 1.450
22/11/2004 23,10 24,50 22,30 22,40 -3,45% 9,52% 12.180
19/11/2004 23,20 23,50 23,10 23,20 -2,11% 1,72% 2.760
18/11/2004 23,50 24,00 23,20 23,70 -1,25% 3,40% 6.370
17/11/2004 23,10 25,80 23,10 24,00 +2,56% 11,69% 2.690
16/11/2004 14,10 23,50 14,10 23,40 -1,27% 66,67% 2.760
15/11/2004 24,79 24,79 23,30 23,70 -0,42% 6,01% 3.160
12/11/2004 24,50 24,50 23,30 23,80 -2,06% 4,90% 2.690
11/11/2004 22,50 25,00 22,50 24,30 +1,25% 11,11% 6.770
10/11/2004 25,00 25,00 23,10 24,00 +3,90% 7,60% 1.910
09/11/2004 23,80 25,00 22,80 23,10 -1,28% 9,24% 6.860
08/11/2004 24,50 25,60 22,30 23,40 +5,41% 13,47% 2.230
05/11/2004 25,30 25,30 22,20 22,20 -9,76% 12,25% 8.250
04/11/2004 26,00 26,90 23,90 24,60 +2,50% 11,54% 14.310
03/11/2004 24,00 25,30 23,80 24,00 -4,00% 6,25% 5.850
02/11/2004 26,00 26,00 24,50 25,00 +0,00% 5,77% 5.400
01/11/2004 27,00 28,90 25,00 25,00 -3,85% 14,44% 5.760
29/10/2004 26,00 27,00 25,50 26,00 +1,17% 5,77% 3.700
28/10/2004 27,00 27,00 25,70 25,70 +0,00% 4,81% 980
27/10/2004 26,50 28,50 25,60 25,70 -2,28% 10,94% 4.760
26/10/2004 27,40 27,50 26,10 26,30 -0,75% 5,11% 1.980
25/10/2004 27,80 27,80 26,50 26,50 -2,21% 4,68% 1.590
22/10/2004 27,60 27,60 26,40 27,10 -0,37% 4,35% 6.400
21/10/2004 26,40 28,00 26,00 27,20 +8,80% 7,58% 7.710
20/10/2004 24,40 28,50 24,40 25,00 +4,17% 16,80% 11.730
19/10/2004 24,00 25,00 23,80 24,00 +0,42% 5,00% 27.370
18/10/2004 23,90 24,00 23,00 23,90 +1,70% 4,18% 1.320
15/10/2004 24,20 24,70 23,30 23,50 -0,84% 5,79% 7.030
14/10/2004 24,20 24,30 23,30 23,70 -1,25% 4,13% 6.600